About one of four adults in the United States reports having a mental health condition, yet many struggle to obtain care due to high costs and limited access to providers. A federal law, the Mental Health Parity and Addiction Equity Act (MHPAEA), aims to safeguard access to behavioral health treatment for people with private health insurance by prohibiting insurers and health plans from putting greater limits on access to behavioral health services than they do for other medical care. In most cases, state insurance regulators are responsible for monitoring insurers’ compliance with MHPAEA within their state’s individual and group markets. The law has bipartisan support and states as varied a Georgia and California have strengthened their ability to enforce its standards.
Last fall, the Biden administration finalized a rule updating standards for MHPAEA, including new requirements for “non-quantitative treatment limits” (NQTLs) — that is, treatment limits that cannot be easily measured yet can impose significant barriers to getting care. An NQTL could be, for instance, a requirement to obtain prior authorization before care is provided, obliging consumers to try lower-cost treatment options before a higher-cost one is approved, or limiting the list of prescription drugs covered by a plan. Although protections in the new rule have drawn a legal challenge from some stakeholders who view them as burdensome, the changes reflect the approach a growing number of states are taking to implement the law.
Requirement to Prove Parity with Outcome Data
To comply with MHPAEA, the new rule requires insurers to collect and analyze outcome data, such as rates of out-of-network utilization and denied claims, to assess whether the treatment limits imposed on services make it harder for consumers to get behavioral health care. A material difference between outcome data for behavioral health services and other care would reflect unequal access and be a strong indicator that an insurer has not complied with the law. Insurers would then be required to take reasonable actions to improve access.
Some states are already using outcome data to identify unequal access and request information on insurers’ practices. The new rule strengthens regulators’ hands because a difference in data obligates insurers to either justify the treatment limit that is creating barriers to access or remove the limit.